What is the recommended dose of phenytoin (antiepileptic medication) oral per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Oral Phenytoin

For adult patients requiring phenytoin therapy, the recommended maintenance dosage is 300-400 mg/day (4-6 mg/kg/day) divided into 1-3 doses. 1

Loading Dose Considerations

  • For patients who require rapid achievement of therapeutic levels, an oral loading dose of 1 gram can be administered, divided into three doses (400 mg, 300 mg, 300 mg) given at two-hour intervals 2
  • Loading doses should only be administered in clinical settings where phenytoin serum levels can be closely monitored 2
  • Patients with renal or liver disease should not receive oral loading regimens 2
  • Therapeutic serum levels (10-20 μg/ml) are typically achieved within 2-4 hours after oral administration 1, 3

Maintenance Dosing

  • For most adults, a satisfactory maintenance dosage is one 100-mg capsule three to four times a day (300-400 mg/day) 2
  • If needed, dosage may be increased up to two capsules three times a day (600 mg/day) 2
  • Once-daily dosing with 300 mg may be considered if seizure control is established with divided doses totaling 300 mg daily 2
  • Only extended phenytoin sodium capsules are recommended for once-a-day dosing 2

Special Considerations

  • Serum concentrations should be monitored when changing between different phenytoin formulations (extended capsules, prompt capsules, or suspension) 2
  • The clinically effective serum level is usually 10–20 mcg/mL 2
  • A period of seven to ten days may be required to achieve steady-state blood levels, so dosage adjustments should not be made at intervals shorter than 7-10 days 2
  • When serum concentrations reach 5-10 μg/ml, subsequent dose adjustments should be made in small increments of about 25 mg to avoid toxicity 4

Monitoring and Safety

  • Monitor for dose-related adverse effects including ataxia, nystagmus, tremor, and somnolence 1
  • Studies show that the majority of patients (85.6%) fail to achieve therapeutic concentrations between 10-20 μg/ml when receiving the standard 300 mg daily dose, highlighting the importance of individualized dosing based on serum level monitoring 5
  • Phenytoin follows Michaelis-Menten pharmacokinetics, meaning small dose increases can lead to disproportionately large increases in serum concentration once the elimination pathway begins to saturate 4, 5

Pediatric Dosing

  • Initial pediatric dosage is 5 mg/kg/day divided into two or three equal doses 2
  • Recommended daily maintenance dosage for children is usually 4-8 mg/kg 2
  • Children over 6 years and adolescents may require the minimum adult dose (300 mg/day) 2
  • Infants in the first three months of life may require higher doses (10-20 mg/kg/day) to achieve therapeutic levels 6

Common Pitfalls to Avoid

  • Changing phenytoin brands or formulations without monitoring serum levels can lead to therapeutic failure or toxicity 2
  • Failing to account for genetic polymorphisms affecting metabolism (CYP2C9 and CYP2C19) may result in unexpected serum concentrations 7
  • Using standard adult dosing in all patients without consideration of individual pharmacokinetics often results in subtherapeutic levels 5
  • Making dosage adjustments too frequently (less than 7-10 days apart) can lead to unpredictable serum levels due to phenytoin's long half-life 2

References

Guideline

Phenytoin Dosage Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Single oral loading dose of phenytoin: a pharmacokinetics study.

Journal of the neurological sciences, 1997

Research

Phenytoin dose adjustment in epileptic patients.

British journal of clinical pharmacology, 1974

Research

Oral dosing requirements for phenytoin in the first three months of life.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.